Halted: What's going on with Sigma shares today?

Sigma investors would be holding their breath right now.

| More on:
Man with his hand out the front, symbolising a trading halt.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a great day for the S&P/ASX 200 Index (ASX: XJO) so far this Wednesday. After a rough and wild session yesterday, the ASX 200 seems to be in full recovery mode, which is good news for investors. But not so much for anyone who owns Sigma Healthcare Ltd (ASX: SIG) shares. At least at first glance.

That's because Sigma Healthcare shares are not active on the ASX today. The healthcare stock closed at $3.03 a share yesterday after enjoying a 12.22% boost following the company's latest earnings report.

As we covered at the time, this was a very impressive update. Sigma informed investors that the unlisted Chemist Warehouse chain delivered a 13% rise in total sales to a record high of $5.15 billion over the first half of the 2025 financial year. Sigma is, of course, barrelling towards a full merger with Chemist Warehouse.

Even more luminous were Chemist Warehouse's profits. Sigma revealed that the pharmacy chain boosted its net profits before tax by a whopping 36.1% to $436.8 million.

It therefore wasn't too shocking to see investors push up the Sigma share price so enthusiastically yesterday.

But today, those shares are frozen at $3.03 each, with trading halted.

Sigma shares halted for crucial Chemist Warehouse merger vote

Yep, this morning, Sigma put out an ASX release just before market open. This release informed investors that Sigma had requested an "immediate implementation of a trading halt". Fortunately, the company provided a detailed explanation as to why this halt was being requested:

The trading halt is requested pending announcements relating to the outcome of the Sigma shareholder meeting and the Chemist Warehouse scheme meeting which will both be held today.

As you know, these meetings relate to the merger between Sigma and Chemist Warehouse, and the passing of certain resolutions at both meetings are conditions precedent to the implementation of the merger.

Sigma requests the trading halt to allow Sigma to manage its continuous disclosure obligations and to ensure that Sigma shares are not trading on an uninformed basis.

Investors have known that this shareholder meeting was to occur today for a while. Sigma's board has already unanimously recommended that shareholders give the deal the green light. That's after the final regulatory approvals were granted late last year. If shareholders vote to proceed with the Chemist Warehouse merger, it will be implemented on 12 February next month.

Given the euphoric response from investors since the merger was first proposed in late 2023, it would be surprising to see it fail this vote. Since December 2023, the Sigma share price has ballooned by roughly 300%, rising from under $1 a share to the $3.03 the company is frozen at today.

Sigma expects its shares to resume trading by tomorrow's session at the latest. At the current share price, the company has a market capitalisation of $4.94 billion.

Should you invest $1,000 in Sigma Healthcare right now?

Before you buy Sigma Healthcare shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Sigma Healthcare wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 7 February 2025

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A businesswoman exhales a deep sigh after receiving bad news, and gets on with it.
Earnings Results

Cochlear share price sinks 10% on half-year result disappointment

Let's see why investors are hitting the sell button this morning.

Read more »

Woman flexes muscles after donating blood.
Healthcare Shares

The CSL share price hit a 52-week low this week. Is it time to buy?

Is this beaten-up biotech a healthy opportunity?

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Sigma share price up 9% on first day of trading post-merger with Chemist Warehouse

It's a post-merger party for Sigma Healthcare shareholders today.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 135% in a year, why this ASX 200 healthcare stock is 'on track to become a truly great Australian success'

A leading fund manager expects more strong performance from this surging ASX 200 healthcare stock.

Read more »

Stethoscope with a piggy bank in the middle.
Healthcare Shares

With revenue up 9%, why does the NIB share price keep falling?

Will the ailing share price make a full recovery?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

Sigma shares have soared over the past year alongside the merger with Chemist Warehouse.

Read more »

Woman with headphones on relaxing and looking at her phone happily.
Healthcare Shares

Everything you need to know about the latest CSL dividend

CSL's latest dividend should be turning investors' heads...

Read more »

thoughtful investor sitting at computer
Healthcare Shares

What are brokers saying about CSL shares after the selloff?

The biotech giant's shares hit a 52-week low yesterday. Is this a buying opportunity?

Read more »